Isodiol International Inc Signs Binding Agreement to Acquire 100% of C3 Global Biosciences

November 24, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a binding agreement to acquire 100% of C3 Global Biosciences (C3GBS), a cause-driven […]

The post Isodiol International Inc Signs Binding Agreement to Acquire 100% of C3 Global Biosciences appeared first on Isodiol.

Read The Full Article @ #IsodiolNews